Northfield, Ill.(November 12, 2026)– Dr. Joe Lennerz has been appointed to the College of American Pathologists (CAP) Board of Governors to fill a recent vacancy and serve the remainder of the term (through September 2027). The Board selected Dr. Lennerz last weekend during its November meeting.
“I am honored to join the CAP Board of Governors at a time of extraordinary opportunity for our profession,” Dr. Lennerz said. “Advances in artificial intelligence, regulatory science, and evolving reimbursement models are reshaping the practice of pathology. I look forward to working with my colleagues to ensure that pathologists help shape these developments, strengthen our profession, and translate innovation into better patient care.”
Dr. Lennerz is a board-certified molecular genetic pathologist and physician-scientist who serves as medical director for pathology innovation at Natera. His work focuses on integrated diagnostics, digital pathology and AI, molecular diagnostics, and regulatory science.
Dr. Lennerz was previously the associate chief of pathology and medical director for the Center for Integrated Diagnostics at Massachusetts General Hospital and a professor at Harvard Medical School. He also served as chief scientific officer at BostonGene.
A long-time CAP member, Dr. Lennerz serves on the CAP Council on Informatics and Pathology Innovation.
###
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.